At the Ohio State University, scientists are using xMAP® Technology to evaluate the molecular effects of this candidate therapy.
Beyond Checkpoint Inhibitors: New Cancer Vaccine Candidate Shows Promising Preclinical Results
Category Archives - xMAP Multiplexing
Scientists Choose xMAP® Technology to Identify Exposure to Pathogens That Cause Lyme Disease
Discover how the NMI Natural and Medical Sciences Institute in Germany harnessed the groundbreaking dual-reporter feature of the xMAP INTELLIFLEX® System to revolutionize Lyme disease antibody testing.
Summarizing the Benefits of Proteomics in Early Cancer Detection
A recently published white paper titled “The Role of Proteomics in Early Cancer Detection: A Look at Six Core Benefits” touches on the collaborative goal between Luminex and Bio-Techne Corporation.
xMAP® ジャーナルクラブ: マルチプレックスアッセイの有用性を示す最近の論文
In the halls of Luminex, we speak about how innovative our customers are. They start with our xMAP® multiplexing technology, but we know that the technology requires the dedication of scientists to power groundbreaking new vaccines, therapies, and diagnostic tests.
カスタムアッセイの開発
Developing your own xMAP® assay can provide several advantages in various fields of study, including medical research, drug discovery, environmental testing, and more. Here are several reasons why you might consider developing your own xMAP assay.
解析が必要な珍しいサンプルをお持ちであれば、Luminexのテクノロジーで実現可能です。
When Luminex began offering its bead-based multiplex xMAP® Technology in the 1990s, our team was convinced that a tool that prioritized versatility would empower scientists in a broad range of research and clinical areas, including biomarker discovery and validation.
ワクチン開発を加速させるマルチプレックス技術
For more than 25 years, this multiplexing tool has supported the research and clinical studies needed for the development and commercialization of new vaccines.
Luminex Licensed Technologies Partner Spotlight: Intercientifica
Prenatal testing and newborn screening programs are among the most effective tools to ensure that babies have the best chance to grow into healthy children. In Brazil, one company has lead the charge in this area for three decades.
At IMMUNOLOGY2023, Multiplex Technology was in the Spotlight
The Luminex team was thrilled to attend IMMUNOLOGY2023, the annual meeting of the American Association of Immunologists. The event is the largest conference dedicated to immunology research in the world, bringing together thousands of experts from academia, industry, and government.
Top Six Challenges in Biomarker Research and Analysis
Here are some helpful tips for the top six challenges of your biomarker research and analysis, as well as how xMAP’s multiplexing technology can help you ensure swift, accurate results and accomplish your goals.